A 33-year-old cisgender woman was diagnosed with HIV 2 years ago. She has taken dolutegravir and tenofovir alafenamide-emtricitabine and has consistently had suppressed HIV RNA levels. Recent laboratory studies showed a CD4 count of 586 cells/mm3 and an undetectable HIV RNA level. She has no other medical problems. Initial laboratory test results at entry into care, including comprehensive metabolic panel, complete blood count, and urinalysis, were normal.
Which one of the following is the recommended approach to monitor for renal dysfunction in this woman?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
October 1st, 2023
October 1st, 2023
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5